354 related articles for article (PubMed ID: 2918589)
1. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
Lee LM; Stevenson RW; Szasz G
J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589
[TBL] [Abstract][Full Text] [Related]
2. Objective double-blind evaluation of erectile function with intracorporeal papaverine in combination with phentolamine and/or prostaglandin E1.
Allen RP; Engel RM; Smolev JK; Brendler CB
J Urol; 1992 Oct; 148(4):1181-3. PubMed ID: 1404632
[TBL] [Abstract][Full Text] [Related]
3. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E1 therapy for impotence, comparison with papaverine.
Earle CM; Keogh EJ; Wisniewski ZS; Tulloch AG; Lord DJ; Watters GR; Glatthaar C
J Urol; 1990 Jan; 143(1):57-9. PubMed ID: 2294263
[TBL] [Abstract][Full Text] [Related]
5. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
von Heyden B; Donatucci CF; Kaula N; Lue TF
J Urol; 1993 May; 149(5 Pt 2):1288-90. PubMed ID: 8479018
[TBL] [Abstract][Full Text] [Related]
6. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B
J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045
[TBL] [Abstract][Full Text] [Related]
7. The change of penile blood thromboxane B2 and prostacyclin after intracavernous injection of vasoactive drugs for the treatment of arteriogenic impotence.
Lin JS; Chang WC; Lui SM
Proc Natl Sci Counc Repub China B; 1994 Jan; 18(1):12-6. PubMed ID: 8029369
[TBL] [Abstract][Full Text] [Related]
8. Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone.
Floth A; Schramek P
J Urol; 1991 Jan; 145(1):56-9. PubMed ID: 1984099
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
[TBL] [Abstract][Full Text] [Related]
10. A prospective double-blind trial of intracorporeal papaverine versus prostaglandin E1 in the treatment of impotence.
Sarosdy MF; Hudnall CH; Erickson DR; Hardin TC; Novicki DE
J Urol; 1989 Mar; 141(3):551-3. PubMed ID: 2645420
[TBL] [Abstract][Full Text] [Related]
11. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
Vardi Y; Lidgi S; Moskovitz B; Levin RD
Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
[TBL] [Abstract][Full Text] [Related]
12. Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction.
Waldhauser M; Schramek P
J Urol; 1988 Sep; 140(3):525-7. PubMed ID: 3045341
[TBL] [Abstract][Full Text] [Related]
13. [Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].
Chandeck Montesa K; Chen Jiménez J; Tamayo JC; Rodríguez Antolín A; Alvarez González E
Actas Urol Esp; 1992 Mar; 16(3):208-16. PubMed ID: 1621545
[TBL] [Abstract][Full Text] [Related]
14. [Prostaglandin E1 in erectile dysfunction].
Porst H
Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
[TBL] [Abstract][Full Text] [Related]
15. Experience with triple-drug therapy in a pharmacological erection program.
Govier FE; McClure RD; Weissman RM; Gibbons RP; Pritchett TR; Kramer-Levien D
J Urol; 1993 Dec; 150(6):1822-4. PubMed ID: 8230514
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
Meinhardt W; Lycklama à Nijeholt AA; Kropman RF; Vermeij P; Zwartendijk J
Eur Urol; 1994; 26(4):319-21. PubMed ID: 7713130
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses.
Bechara A; Casabé A; Chéliz G; Romano S; Fredotovich N
J Urol; 1996 Mar; 155(3):913-4. PubMed ID: 8583605
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, cross-over study comparing prostaglandin E1 and papaverine in patients with vasculogenic impotence.
Kattan S; Collins JP; Mohr D
Urology; 1991 Jun; 37(6):516-8. PubMed ID: 2038782
[TBL] [Abstract][Full Text] [Related]
19. Effect of multidose intracorporeal injection and audiovisual sexual stimulation in vasculogenic impotence.
Katlowitz N; Albano GJ; Patsias G; Golimbu M; Morales P
Urology; 1993 Dec; 42(6):695-7. PubMed ID: 8256402
[TBL] [Abstract][Full Text] [Related]
20. Comparative value of prostaglandin E1 and papaverine in treatment of erectile failure: double-blind crossover study among Egyptian patients.
Mahmoud KZ; el Dakhli MR; Fahmi IM; Abdel-Aziz AB
J Urol; 1992 Mar; 147(3):623-6. PubMed ID: 1538443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]